Drug Trial Radar · NCT06939296
A Research Study of VCT220 in Adult Chinese Participants With Obesity
Last checked: Nov 19, 2026Latest source record: Sep 16, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
840
Actual
Start
Dec 24, 2024
Primary completion
Nov 25, 2025
Study completion Mar 31, 2026
Sponsor
- Lead sponsor
- Vincentage Pharma Co., LtdIndustry
- Sponsor type
- Industry
- First posted
- Apr 22, 2025
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The main purpose of this study is to assess how VCT220 tablets affect the bodyweight in obese or overweight adult participants. Participant will be randomly assigned to the high-dose group, low-dose group, or placebo group. Each participant will take the study drug orally once daily for 12 months.
Conditions
- Obesity
- Overweight
Interventions
VCT220Drug
A small molecule GLP-1R drug, film coated tablet
PlaceboDrug
Placebo tablets
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percentage change from baseline in body weightTime frame: From baseline to week 34
- The proportion of subjects with a body weight reduction ≥5% from baselineTime frame: From baseline to week 34
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Peking University People's Hospital ( There are multiple sites in this clinical trial)
Beijing, Beijing Municipality, China
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.